Skip Navigation LinksHome > December 2013 - Volume 73 - Issue 6 > Intradural Extramedullary Spinal Metastases of Non-neurogeni...
doi: 10.1227/NEU.0000000000000132
Research-Human-Clinical Studies

Intradural Extramedullary Spinal Metastases of Non-neurogenic Origin: A Distinct Clinical Entity or a Subtype of Leptomeningeal Metastasis? A Case-Control Study

Knafo, Steven MD‡,*; Pallud, Johan MD§,¶,*; Le Rhun, Emilie MD; Parker, Fabrice MD#; Iakovlev, Gueorgui MD**; Roux, François-Xavier MD§,¶; Page, Philippe MD§,¶; Meder, Jean-François MD§,‡‡; Emery, Evelyne MD§§; Devaux, Bertrand MD§,¶; the Club de Neuro-oncologie of the Société Française de Neurochirurgie

Collapse Box


BACKGROUND: Leptomeningeal metastases from carcinoma are still poorly understood.

OBJECTIVE: To better define the management of unique intradural extramedullary spinal metastases (IESM) from solid cancers of non-neurogenic origin, in particular regarding leptomeningeal metastasis (LM).

METHODS: We conducted a retrospective, multicenter, case-control study including 11 patients with IESM matched with 11 patients with LM. Primary endpoint was overall survival; secondary endpoints were diagnostic criteria and prognostic factors.

RESULTS: Descriptive analysis showed a clinically significant difference between IESM and LM patients regarding preexisting neurological deficit (45.5% vs 90.1%, P = .06) and malignant cells in cerebrospinal fluid (0% vs 54.5%, P = .03). The median overall survival was significantly higher for IESM patients (732 days) than for patients with LM (53 days; P < .0002). Multivariate analysis showed that preexisting neurological deficit was a negative prognostic factor for overall survival (hazard ratio: 10.2; 95% confidence interval: 1.88-102; P = .04), in contrast to functional improvement with treatment (hazard ratio: 0.01; 95% confidence interval: 0.00-0.52; P = .04). We propose the following diagnostic criteria for IESM: (1) a solid lesion located within the intradural extramedullary space, (2) the absence of other leptomeningeal lesion seen on full-spine injected magnetic resonance imaging, (3) the absence of malignant cells in cerebrospinal fluid, and (4) a histological confirmation of the metastatic nature of the lesion.

CONCLUSION: The significant difference in survival between IESM and LM suggests that they are 2 distinct evolutions of the metastatic disease. Distinguishing IESM also has therapeutic consequences because patients can benefit from a focal surgical treatment with functional improvement and extended survival.

ABBREVIATIONS: IESM, intradural extramedullary spinal metastases

LM, leptomeningeal metastasis

Copyright © by the Congress of Neurological Surgeons


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.